Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-25-009355

EVP, Chief Commercial Officer sold 26,771 shares at $43.62 ($1,167,751)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Callos Andrew · EVP, Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-13 Sale : show line 1 in the form 10b5-1 −26,771 $43.62 $1,167,751 37,663 D
Open-market sales · 26,771 sh · avg $43.62 · $1,167,751
Loading xslF345X05/form4.xml…